Dieter Hoelzer

Frankfurt Am Main, HE, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications

Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.

Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.

Journal: Leukemia & lymphoma
Published: August 02, 2026

Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia.

Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia.

Journal: Bone marrow transplantation
Published: June 01, 2025

Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.

Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.

Journal: Leukemia & lymphoma
Published: February 08, 2025

Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet.

Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet.

Journal: The Lancet. Haematology
Published: June 17, 2024

Management of ALL in adults: 2024 ELN recommendations from a European expert panel.

Management of ALL in adults: 2024 ELN recommendations from a European expert panel.

Journal: Blood
Published: December 19, 2023

Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review.

Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review.

Journal: Leukemia & lymphoma
Published: August 01, 2023

Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.

Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.

Journal: Blood
Published: July 11, 2023

Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment.

Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment.

Journal: Scientific reports
Published: June 08, 2023

ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia.

ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 27, 2023

Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemia.

Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemia.

Journal: Blood reviews
Published: November 17, 2022

Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.

Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.

Journal: Transplantation and cellular therapy
Published: June 14, 2022

Chemotherapy-free Treatment - A New Era in Acute Lymphoblastic Leukemia?

Chemotherapy-free Treatment - A New Era in Acute Lymphoblastic Leukemia?

Journal: The New England journal of medicine
Published: October 21, 2020
Showing 1-12 of 82

Last Updated: 09/26/2026